KRAS and lung adenocarcinoma: Furthermore, while context-dependent tumor suppressive activity of AMBRA1 has been associated with oncogenic KRAS signaling in lung adenocarcinoma [42], we did not find any correlation of KRAS and AMBRA1 in tumors which show recurrent oncogenic KRAS mutations (Additional file 1: Fig. 10E).